Loading...

Qiagen N.V.

QGEN•NYSE
Healthcare
Medical - Diagnostics & Research
$38.41
$0.44(1.16%)
U.S. Market opens in 23h 4m

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.9B
P/E Ratio18.66
EPS (TTM)$2.04
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$44.90
3 Months$50.63
1 Year Target$49.23

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.66 and a market capitalization of 7.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.11%
5-Day Change
-8.16%
1-Month Change
-3.49%
3-Month Change
-30.98%
6-Month Change
-22.16%
Year-to-Date (YTD) Change
-18.91%
1-Year Change
-10.85%
3-Year Change
-16.31%
5-Year Change
-25.57%
All-Time (Max) Change
1838.89%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

5,700 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions